Vincenzo Solfrizzi Selected Research

Vincenzo Solfrizzi Research Topics

Disease

83	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 09/2002
53	Cognitive Dysfunction 04/2024 - 04/2005
42	Dementia (Dementias) 06/2023 - 04/2005
10	Frailty 12/2023 - 04/2012
8	Amyloid Plaque 08/2022 - 02/2006
7	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 10/2010 - 09/2002
6	Inflammation (Inflammations) 12/2023 - 02/2006
6	Hypertension (High Blood Pressure) 08/2023 - 04/2006
4	Neuroinflammatory Diseases 04/2024 - 08/2022
4	Tauopathies 04/2024 - 01/2023
4	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 04/2024 - 01/2016
4	Neurobehavioral Manifestations 01/2020 - 08/2009
4	Stroke (Strokes) 08/2016 - 04/2006
4	Meningoencephalitis 03/2014 - 11/2010
4	Edema (Dropsy) 02/2012 - 11/2010
4	Vascular Diseases (Vascular Disease) 12/2009 - 03/2003
4	Coronary Artery Disease (Coronary Atherosclerosis) 07/2008 - 04/2002
4	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2007 - 04/2006
3	Parkinson Disease (Parkinson's Disease) 01/2023 - 11/2008
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 04/2002
3	Malnutrition (Nutritional Deficiencies) 09/2010 - 11/2006
3	Atherosclerosis 04/2010 - 04/2006
2	Disease Progression 04/2024 - 03/2011
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2024 - 09/2010
2	Language Development Disorders (Semantic-Pragmatic Disorder) 01/2021 - 01/2014
2	Depressive Disorder (Melancholia) 01/2020 - 01/2018
2	Frontotemporal Dementia (Semantic Dementia) 01/2016 - 08/2006
2	Hallucinations (Hallucination) 01/2012 - 04/2011
2	Pain (Aches) 10/2010 - 07/2009
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2010 - 06/2008
1	Parkinsonian Disorders (Parkinsonism) 04/2024
1	Anxiety Disorders (Anxiety Disorder) 06/2023

Drug/Important Bio-Agent (IBA)

28	Amyloid (Amyloid Fibrils)IBA 04/2024 - 04/2004
25	ApolipoproteinsIBA 12/2023 - 03/2003
21	Apolipoproteins E (ApoE)IBA 12/2023 - 03/2003
19	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2018 - 04/2005
11	Peptides (Polypeptides)IBA 01/2023 - 01/2009
11	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2004
11	Fatty Acids (Saturated Fatty Acids)IBA 12/2018 - 04/2005
10	Biomarkers (Surrogate Marker)IBA 12/2023 - 02/2006
10	Monounsaturated Fatty AcidsIBA 01/2017 - 04/2005
9	Monoclonal AntibodiesIBA 04/2024 - 11/2010
8	Amyloid beta-PeptidesIBA 06/2023 - 09/2002
8	AntioxidantsIBA 12/2018 - 03/2006
8	CholesterolIBA 04/2009 - 02/2006
7	tau Proteins (tau Protein)IBA 04/2024 - 12/2009
7	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2017 - 05/2009
7	bapineuzumabIBA 10/2014 - 11/2010
7	Type A Botulinum Toxins (Botox)FDA Link 10/2010 - 11/2008
6	solanezumabIBA 04/2024 - 02/2012
6	VaccinesIBA 06/2023 - 11/2010
6	Lipoproteins (Lipoprotein)IBA 12/2009 - 04/2002
5	Lipoprotein(a)IBA 12/2007 - 04/2002
4	Protein Isoforms (Isoforms)IBA 04/2024 - 02/2006
4	Carrier Proteins (Binding Protein)IBA 07/2023 - 01/2019
4	AntibodiesIBA 07/2023 - 02/2012
4	LipidsIBA 09/2019 - 04/2006
4	AN-1792IBA 03/2014 - 11/2010
4	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2012 - 01/2009
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 10/2004
3	IronIBA 11/2021 - 11/2006
3	gantenerumabIBA 01/2018 - 03/2014
3	HomocysteineIBA 01/2018 - 02/2006
3	MicronutrientsIBA 01/2018 - 03/2008
3	Vitamin B Complex (B Vitamins)IBA 05/2009 - 03/2006
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2009 - 04/2006
2	CarbohydratesIBA 08/2023 - 11/2006
2	Amyloidogenic ProteinsIBA 07/2023 - 12/2016
2	gosuranemabIBA 01/2023 - 01/2016
2	Apolipoprotein E4IBA 01/2022 - 12/2011
2	Apolipoprotein E2IBA 01/2022 - 09/2010
2	SodiumIBA 01/2022 - 11/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2006
2	Cholinergic Agents (Cholinergics)IBA 01/2020 - 12/2016
2	Antipsychotic Agents (Antipsychotics)IBA 01/2016 - 01/2015
2	hydromethylthionineIBA 01/2016 - 01/2016
2	Humanized Monoclonal AntibodiesIBA 10/2014 - 09/2014
2	EnzymesIBA 01/2012 - 03/2011
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2010 - 06/2008
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2010 - 12/2009
2	ZincIBA 01/2010 - 11/2006
2	CopperIBA 01/2010 - 11/2006
2	Drinking WaterIBA 01/2010 - 11/2006
2	AluminumIBA 01/2010 - 11/2006
2	oxidized low density lipoproteinIBA 09/2009 - 03/2005
2	S-Adenosylmethionine (Ademetionine)IBA 05/2009 - 01/2009
2	S-AdenosylhomocysteineIBA 01/2009 - 03/2008
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2009 - 03/2006
2	Cathepsin DIBA 02/2008 - 08/2005
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 04/2024
1	MicroRNAs (MicroRNA)IBA 12/2023

Therapy/Procedure

15	Therapeutics 04/2024 - 11/2008
10	Immunotherapy 07/2023 - 11/2010
7	Mediterranean Diet 01/2014 - 10/2006
6	Secondary Prevention 08/2022 - 01/2010
5	Institutionalization (Institutionalized Persons) 01/2023 - 01/2007
4	Activities of Daily Living (ADL) 01/2016 - 01/2007
3	Continuous Ambulatory Peritoneal Dialysis (CAPD) 01/2021 - 01/2014
2	Drug Therapy (Chemotherapy) 04/2024 - 01/2018
2	Injections 10/2010 - 10/2009